cancer immunotherapy Archives -

Preparing for the next decade of innovation in immuno-oncology

https://pharmaphorum.com/oncology/immuno-oncology-clinicial-trial-market-access/

Gilead poaches oncology expert Quigley from BMS

https://pharmaphorum.com/news/gilead-poaches-oncology-expert-quigley-from-bms/

AZ joins with Seres to research role of gut microbiome in cancer

https://pharmaphorum.com/news/az-joins-with-seres-to-research-role-of-gut-microbiome-in-cancer/

Keytruda could get patient-friendly 6 week dosing schedule in EU

https://pharmaphorum.com/news/keytruda-could-get-patient-friendly-6-week-dosing-schedule-in-eu/

Celgene signs brace of immuno-oncology deals with US biotechs

https://pharmaphorum.com/news/celgene-signs-brace-of-immuno-oncology-deals-with-us-biotechs/

Frazier to stay on as Merck CEO, as company axes retirement policy

https://pharmaphorum.com/news/frazier-to-stay-on-as-merck-ceo-as-company-axes-retirement-policy/

Latest lung cancer data could open new avenue for Roche’s Tecentriq

https://pharmaphorum.com/news/latest-lung-cancer-data-could-open-new-avenue-for-roches-tecentriq/

Communication problems holding back new cancer treatments

https://pharmaphorum.com/oncology/communication-problems-holding-back-new-cancer-treatments/

Affimed and Roche ink $5bn plus cancer immunotherapy deal

https://pharmaphorum.com/news/affimed-and-roche-ink-5bn-plus-cancer-immunotherapy-deal/

Search